BIOMAT Database Logo BIOMAT Database Logo

Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. 2005

Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Department of Internal Medicine, Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, the Netherlands. T.Rowshani@amc.uva.nl

Primary cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in recipients after solid organ transplantation (SOT). Widespread and prolonged use of antiviral drugs has changed the natural course of CMV disease by delaying its onset and causing drug resistance. CMV induces a strong cellular immune response, even in immunosuppressed patients, and has developed strategies to evade this immune surveillance. This review summarizes challenges in managing CMV infection in transplant recipients and highlights current insights in the cellular immune response against CMV.

UI MeSH Term Description Entries
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D016377 Organ Transplantation Transference of an organ between individuals of the same species or between individuals of different species. Grafting, Organ,Transplantation, Organ,Graftings, Organ,Organ Grafting,Organ Graftings,Organ Transplantations,Transplantations, Organ

Related Publications

Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Cytomegalovirus infection in solid organ transplant recipients.
September 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
April 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Relapsing cytomegalovirus infection in solid organ transplant recipients.
December 2009, Transplant infectious disease : an official journal of the Transplantation Society,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Management of cytomegalovirus infection in solid-organ transplant recipients.
January 1997, Immunological investigations,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Cytomegalovirus in solid organ transplant recipients.
December 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Indirect effects of cytomegalovirus infection in solid organ transplant recipients.
January 2008, Enfermedades infecciosas y microbiologia clinica,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
[Monitoring techniques in cytomegalovirus infection in solid organ transplant recipients].
December 2011, Enfermedades infecciosas y microbiologia clinica,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients.
August 2004, Current opinion in infectious diseases,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.
December 2002, Transplant infectious disease : an official journal of the Transplantation Society,
Ajda T Rowshani, and Frederike J Bemelman, and Ester M M van Leeuwen, and René A W van Lier, and Ineke J M ten Berge
Cytomegalovirus prophylaxis in solid organ transplant recipients.
May 1996, Transplantation,
Copied contents to your clipboard!